Question 1

What are the potential benefits and risks of adding Roflumilast to my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy clinical trial (NCT05796271). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to standard treatment options available to me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy clinical trial (NCT05796271). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from Roflumilast and R-CHOP?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy clinical trial (NCT05796271). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy clinical trial (NCT05796271). Contact the study team or your healthcare provider for specific answers.

Question 5

What will happen if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy clinical trial (NCT05796271). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific tests or monitoring I will need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy clinical trial (NCT05796271). Contact the study team or your healthcare provider for specific answers.

What this study is about